Advertisement

The clinical pharmacist’s contributions within the multidisciplinary patient care team of an intern nephrology ward

  • Gunar StemerEmail author
  • Rosa Lemmens-Gruber
Short Research Report

Abstract

Objective To describe and evaluate newly implemented clinical pharmacy services and ward round participation on a specialized nephrology ward in a large tertiary care hospital. Method All issues addressed by the clinical pharmacist were systematically collected, and the contributions were classified by type. Where applicable, physicians’ acceptance rates were recorded. The drugs most commonly affected by the clinical pharmacist’s contributions are described. Results A total of 158 clinical pharmacist’s contributions were recorded. Approximately 90% (n = 104) of applicable suggestions (117 out of 158; 74%) were accepted by the treating physicians. Most issues were discussed with physicians (85%); the remaining issues were discussed with nurses and medical students. Antimicrobials, drugs affecting the alimentary system and metabolism, and cardiovascular drugs were among the most commonly affected drugs. Issues concerning dosage and drug-therapy selection were common. The clinical pharmacist was also involved in developing dosing guidelines and performing literature searches. Conclusion The observed effects of a newly implemented clinical pharmacy service on an internal nephrology ward are encouraging; acceptance rates of suggestions and the multidisciplinary appreciation of clinical pharmacy services are high.

Keywords

Austria Clinical pharmacy services Kidney Nephrology 

Notes

Acknowledgments

We would like to thank the multi-professional health care team of the internal nephrology ward for their continuous support during the study period.

Funding

The study was carried out as part of a perennial clinical pharmacy project that was funded by Amgen Austria. Amgen Austria was not involved in study design, data collection and manuscript preparation at any time.

Conflicts of interest

No conflict of interest.

References

  1. 1.
    American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28(6):816–7.Google Scholar
  2. 2.
    Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155(18):1949–56.PubMedCrossRefGoogle Scholar
  3. 3.
    Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407.PubMedCrossRefGoogle Scholar
  4. 4.
    Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Manley HJ, Carroll CA. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial. 2002;15(1):45–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Stemer G, Lemmens-Gruber R. Clinical pharmacy services and solid organ transplantation: a literature review. Pharm World Sci. 2010;32(1):7–18.PubMedCrossRefGoogle Scholar
  8. 8.
    Manley HJ, Cannella CA, Bailie GR, St Peter WL. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis. Am J Kidney Dis. 2005;46(4):669–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Schuhmacher C, Amann S. Drug information from the hospital pharmacy [German]. Krankenhauspharmazie. 2009;30(3):119–26.Google Scholar
  10. 10.
    WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2011. http://www.whocc.no/atc_ddd_index/.
  11. 11.
    Surugue J, Vulto AG. Workforce of EU hospitals and pharmacy services: a direct patient safety issue. Eur J Hosp Pharm Pract. 2006;12:3.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  1. 1.Pharmacy DepartmentVienna General HospitalViennaAustria
  2. 2.Department of Pharmacology and ToxicologyUniversity of ViennaViennaAustria

Personalised recommendations